Cheryl Corcoran, MD
Cheryl Corcoran, MD, is an Associate Professor of Psychiatry and the Program Leader in Psychosis Risk at the Icahn School of Medicine at Mount Sinai. Her research focuses on risk states and identifying brain mechanisms that underlie language disturbance and emotion recognition deficits in this population.
Yulia Landa, PsyD, MS
Yulia Landa, PsyD, MS, is an Assistant Professor of Psychiatry at Mount Sinai School of Medicine and Director of the Psychology Fellowship Program at the James J Peters VA Medical Center. Her research focuses on developing and evaluating targeted Cognitive Behavioral Therapy (CBT) interventions for the treatment and prevention of psychosis and identifying critical mechanisms (psychological and neurobiological) of their effects. She has established individual, group and family-based CBT programs for patients experiencing delusions, paranoia and voice-hearing. Dr. Landa has developed CBT for psychosis training programs and has been teaching clinicians both in the US and internationally.
Shaynna Herrera, PhD
Project Director, CUE
Dr. Herrera is an Instructor at the Icahn School of Medicine at Mount Sinai and a licensed clinical psychologist who serves as the Project Director of CUE. She earned her PhD in Clinical Psychology from the Ferkauf Graduate School of Psychology of Yeshiva University and completed her doctoral internship at the UCLA Semel Institute for Neuroscience and Human Behavior in Adolescent Serious Mental Illness. Dr. Herrera’s clinical expertise is in the evaluation and treatment of individuals with psychosis and psychosis risk. Her research interests include improving engagement and the delivery of psychoeducation to individuals in the early stages of psychosis, and evaluating visual perceptual deficits in psychosis and their contribution to cognitive and functional outcomes.
Dolores Malaspina, MD
Director, Psychosis Program
Dolores Malaspina, MD, MS, MSPH directs the Psychosis Program for the Mount Sinai Health System. She is a professor of psychiatry, neuroscience, genetics, and genomics at the Icahn School of Medicine. Her research has illuminated important risk pathways for severe mental disorders. Dr. Malaspina trained in psychiatry and epidemiology at Columbia Universtity and New York Psychiatric Institute, founding and directing its Schizophrenia Research Unit. Subsequently, she was the chairman of psychiatry at NYU/Bellevue where she established a multidisciplinary Institute for Social and Psychiatric Initiatives (INSPIRES). She is an expert in the diagnosis and treatment of mental disorders, serving on the steering committee for the American Psychiatric Association for the Diagnostic and Statistical Manual of Mental Disorders (DSM).
Jessica Egles, LCSW
Director P.E.E.R First Episode Program, St. Luke’s
Jessica Egles, LCSW, earned a master’s degree from Columbia University School of Social Work. She currently serves as a primary therapist within the Psychiatric Recovery Center and as Director of the P.E.E.R First Episode Program. Jessica completed her SIFI Certification from Columbia University and has served as clinical supervisor to master’s level social work trainees in the clinic. Her interests include the prevention and treatment of psychotic disorders, specifically aimed at interventions to improve the trajectory and recovery of the young adult population.
Laura Bevilacqua, MD, PhD
Mood and Anxiety Program Liaison
Laura Bevilacqua, MD, PhD, is an Assistant Professor in the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai. She joined the Mood and Anxiety Disorders Program, a clinical research group. Her hope is to contribute to the development of programs integrating clinical care and research in order to provide patients with the most effective treatments as well as compassionate, ethical and culturally sensitive care.
Icelini Garcia-Sosa, MD
Director, CUE Beth Israel (coming soon)
Icelini Garcia-Sosa, MD, joined the faculty in 2017 as the Director of Adult Ambulatory Psychiatric Services at Mount Sinai St Luke’s and West. She completed residency training at SUNY Downstate followed by a clinical research fellowship in psychosis at Yale School of Medicine. Her interests and research experience include CBT for psychosis, psychosis risk/proneness, autoimmune disorders, and cultural psychiatry. She has been involved in launching CUE St. Luke’s and currently serves as a key clinician for this program.
Caridad Benavides, MD
Director, CUE St. Luke's
Caridad Benavides, MD, is a bilingual (English, Spanish) MD, PhD candidate who is currently working as Program director for both CUE Icahn and CUE St. Luke’s. She brings a transcultural approach to CUE due to her past experience working outside of the U.S. She worked in specialized continuing care teams for prevention and early intervention in psychosis, helping young adults in Australia and Spain. Her current interests include neuroimaging, as well as prevention and early intervention in severe mental disorders.
Alison Welch, MD
Director, CUE Fifth Avenue
Alison Welch, MD, came to psychiatry after training for a career in classical ballet at the School of American Ballet at Lincoln Center. During her General Adult Psychiatry Residency at the Icahn School of Medicine at Mount Sinai, she was selected to be Chief Resident. She co-founded the Icahn School of Medicine at Mount Sinai Department of Psychiatry Women's Career Development Program to serve as a formalized mentorship forum for both residents and faculty. She has worked as a clinician within the Mood and Anxiety Disorders Research Program. In 2017, she was promoted to Director of the Ambulatory Psychiatry Resident Clinic.